tiprankstipranks
Trending News
More News >
Qualigen Therapeutics Inc (QLGN)
:QLGN
US Market

Qualigen Therapeutics (QLGN) Income Statement

Compare
715 Followers

Qualigen Therapeutics Income Statement

Last quarter (Q3 2025), Qualigen Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Qualigen Therapeutics's net income was $-2.04M. See Qualigen Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 5.20M$ 4.98M$ 5.65M$ 4.31M
Gross Profit
$ 0.00$ -4.50K$ 680.80K$ 1.32M$ -2.88M
Operating Expenses
$ 5.76M$ 6.10M$ 18.62M$ 23.98M$ 9.80M
Depreciation and Amortization
$ 0.00$ 4.50K$ 12.16K$ 322.06K$ 138.65K
EBITDA
$ -5.24M$ -11.30M$ -13.84M$ -22.34M$ -11.16M
Operating Income
$ -5.76M$ -11.30M$ -17.94M$ -22.66M$ -12.68M
Other Income/Expenses
$ -391.14K$ -1.17M$ 872.81K$ 4.77M$ -7.74M
Pretax Income
$ -6.15M$ -12.48M$ -21.30M$ -17.89M$ -20.42M
Net Income
$ -6.16M$ -13.42M$ -21.03M$ -17.90M$ -20.42M
Per Share Metrics
Basic EPS
$ -17.28$ -2.46$ -5.48$ -6.10$ -7.98
Diluted EPS
$ -17.28$ -2.46$ -5.48$ -6.10$ -7.89
Weighted Average Shares Outstanding
361.59K 5.07M 3.84M 2.93M 2.56M
Weighted Average Shares Outstanding (Diluted)
361.59K 5.07M 3.84M 2.93M 2.59M
Currency in USD

Qualigen Therapeutics Earnings and Revenue History